லிசா ஓஊல்ளேத்டே News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from லிசா ஓஊல்ளேத்டே. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In லிசா ஓஊல்ளேத்டே Today - Breaking & Trending Today

U.S. move to loosen vaccine patents will draw drug companies to bargain -lawyers

Publishing date: May 07, 2021 • 6 hours ago • 3 minute read •
Article content
U.S. support for waiving intellectual property rights on COVID-19 vaccines could be a tactic to convince drugmakers to back less drastic steps like sharing technology and expanding joint ventures to quickly boost global production, lawyers said on Thursday.
“I think the end result that most players are looking for here is not IP waiver in particular, it’s expanded global access to the vaccines,” said Professor Lisa Ouellette of Stanford Law School.
We apologize, but this video has failed to load.
Try refreshing your browser, or
U.S. move to loosen vaccine patents will draw drug companies to bargain -lawyers Back to video ....

New York , United States , David Gregorio , Stephane Bancel , Peter Henderson , Lisa Ouellette , Prashant Yadav , Micaela Modiano , Carl Odonnell , Brian Newell , Blake Brittain , Thomas Kowalski , Modiano Parners , Duane Morris , Sarah Rajec , Caroline Humer , Stanford Law School , William Mary Law School , Postmedia Network Inc , World Trade Organization , Professor Lisa Ouellette , Stanford Law , Joe Biden , Chief Executive Stephane Bancel , Mary Law School , Pharmaceutical Research ,

U.S. move to loosen vaccine patents will draw drug companies to bargain: lawyers

By Syndicated Content
By Michael Erman and Blake Brittain
(Reuters) – U.S. support for waiving intellectual property rights on COVID-19 vaccines could be a tactic to convince drugmakers to back less drastic steps like sharing technology and expanding joint ventures to quickly boost global production, lawyers said on Thursday.
“I think the end result that most players are looking for here is not IP waiver in particular, it’s expanded global access to the vaccines,” said Professor Lisa Ouellette of Stanford Law School.
President Joe Biden on Wednesday supported a proposal to waive World Trade Organization intellectual property (IP) rules, which would allow poorer countries to produce vaccine for themselves. So far COVID-19 vaccines have been distributed primarily to the wealthy countries that developed them, while the pandemic sweeps through poorer ones, like India. ....

New York , United States , David Gregorio , Peter Henderson , Stephane Bancel , Lisa Ouellette , Prashant Yadav , Carl Odonnell , Micaela Modiano , Brian Newell , Blake Brittain , Thomas Kowalski , Modiano Parners , Duane Morris , Sarah Rajec , Caroline Humer , Stanford Law School , William Mary Law School , World Trade Organization , Michael Erman , Professor Lisa Ouellette , Stanford Law , Joe Biden , Chief Executive Stephane Bancel , Mary Law School , Pharmaceutical Research ,

Analysis: U.S. move to loosen vaccine patents will draw drug companies to bargain -lawyers

May 7, 20219:08 AM UTC
Healthcare & PharmaceuticalsAnalysis: U.S. move to loosen vaccine patents will draw drug companies to bargain -lawyers
Michael ErmanBlake Brittain
1/4
A medical worker prepares a dose of Oxford/AstraZeneca s COVID-19 vaccine at a vaccination centre in Antwerp, Belgium March 18, 2021. REUTERS/Yves Herman
Read More
U.S. support for waiving intellectual property rights on COVID-19 vaccines could be a tactic to convince drugmakers to back less drastic steps like sharing technology and expanding joint ventures to quickly boost global production, lawyers said on Thursday.
I think the end result that most players are looking for here is not IP waiver in particular, itâs expanded global access to the vaccines, said Professor Lisa Ouellette of Stanford Law School. ....

United States , Stephane Bancel , Lisa Ouellette , Prashant Yadav , Micaela Modiano , Brian Newell , Thomas Kowalski , Modiano Parners , Duane Morris , Sarah Rajec , Stanford Law School , Thomson Reuters Trust Principles , William Mary Law School , World Trade Organization , Professor Lisa Ouellette , Stanford Law , Joe Biden , Chief Executive Stephane Bancel , Mary Law School , Pharmaceutical Research , Thomson Reuters Trust , ஒன்றுபட்டது மாநிலங்களில் , லிசா ஓஊல்ளேத்டே , பிரஷண்ட் யாதவ் , பிரையன் ந்யூயெல் , தாமஸ் கோவல்ஸ்கி ,

U.S. move to loosen vaccine patents will draw drug companies to bargain - lawyers

It looks like this was the result of either:
A mistyped address
A broken link on our site
A broken link on a search engine results page
A broken link on someone else s page
Some things to try:
Use the navigation menu at the top
Most Read ....

Lisa Ouellette , Stanford Law School , Professor Lisa Ouellette , Stanford Law , லிசா ஓஊல்ளேத்டே , ஸ்டான்போர்ட் சட்டம் பள்ளி , ஸ்டான்போர்ட் சட்டம் ,

US move to loosen vaccine patents will draw drug companies to bargain

US move to loosen vaccine patents will draw drug companies to bargain
Modified7:58 am
-
US support for waiving intellectual property rights on Covid-19 vaccines could be a tactic to convince drugmakers to back less drastic steps like sharing technology and expanding joint ventures to quickly boost global production, lawyers said on Thursday.
“I think the end result that most players are looking for here is not IP waiver in particular, it’s expanded global access to the vaccines,” said Professor Lisa Ouellette of Stanford Law School.
All Access Plan ....

Lisa Ouellette , Stanford Law School , Professor Lisa Ouellette , லிசா ஓஊல்ளேத்டே , ஸ்டான்போர்ட் சட்டம் பள்ளி ,